Rapid Onboarding for Master Protocols
Facilitating the rapid onboarding of new treatment arms in Master Protocols can be a challenging task for the study’s operational leaders. Thus, being ready for this task is extremely important. To be successful, these leaders need to facilitate a comprehensive understanding across the e-clinical ecosystem to identify all activities required when adding a new treatment.
Typically, the study’s Interactive Response Technology (IRT) system is designed with a flexible randomisation scheme to accommodate new treatments. However, the designated team members who are managing the randomisation must know exactly how it is to be used in practice. In addition, other activities (e.g., medication packaging, shipping, etc.) required for new treatment onboarding must be identified and well-coordinated. To get the involved team ready, it is crucial to crystallise the process broadly in terms that all team members can understand. Effective leaders will foster a collaborative process where teams develop empathy for the objectives and challenges of other team members, vendors, and operations partners.View Resource
Almac Clinical Technologies
Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.
Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.
Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.